Literature DB >> 25343959

Thrombospondin 1 requires von Willebrand factor to modulate arterial thrombosis in mice.

Prem Prakash1, Paresh P Kulkarni1, Anil K Chauhan1.   

Abstract

Thrombospondin 1 (TSP1) has been suggested as a counter receptor to platelet glycoprotein Ibα that supports initial platelet adhesion in absence of von Willebrand factor (VWF). Conversely, several other studies have shown that TSP1 interacts with VWF and may play a mechanistic role in modulating thrombosis. However, the in vivo evidence to support this mechanism remains unclear. Using intravital microscopy, in a 10% FeCl3-induced thrombosis model, we report similar platelet adhesion in Tsp1(-/-)/Vwf(-/-) mice compared with littermate Vwf(-/-) mice, suggesting that TSP1 does not mediate initial platelet adhesion in the absence of VWF. Tsp1(-/-) mice exhibited prolonged occlusion time and a significant decrease in the rate of thrombus growth (P < .05 vs wild-type), but not in the initial platelet adhesion. Complete deficiency of VWF abrogated the rate of thrombus growth in Tsp1(-/-) mice; therefore, we generated Tsp1(-/-)/Vwf(+/-) mice to determine whether TSP1 modulates thrombus growth under conditions of partial VWF deficiency. Tsp1(-/-)/Vwf(+/-) mice exhibited delayed thrombus growth kinetics and prolonged occlusion time (P < .05 vs Vwf(+/-)). Finally, we demonstrate that platelet-derived TSP1 modulates arterial thrombosis in vivo. We conclude that TSP1 released from platelets plays a mechanistic role in modulating thrombosis in the presence of VWF.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25343959      PMCID: PMC4314536          DOI: 10.1182/blood-2014-06-581942

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

Authors:  Anil K Chauhan; Janka Kisucka; Colin B Lamb; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo.

Authors:  H Yang; A Reheman; P Chen; G Zhu; R O Hynes; J Freedman; D D Wagner; H Ni
Journal:  J Thromb Haemost       Date:  2006-07-05       Impact factor: 5.824

Review 3.  Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice.

Authors:  Wolfgang Bergmeier; Anil K Chauhan; Denisa D Wagner
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

4.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

5.  Thrombospondin-1 and ADAMTS13 competitively bind to VWF A2 and A3 domains in vitro.

Authors:  Anyou Wang; Fang Liu; Ningzheng Dong; Zhenni Ma; Jingyu Zhang; Jian Su; Yiming Zhao; Changgeng Ruan
Journal:  Thromb Res       Date:  2010-08-11       Impact factor: 3.944

6.  Prothrombotic effects of fibronectin isoforms containing the EDA domain.

Authors:  Anil K Chauhan; Janka Kisucka; Maria R Cozzi; Meghan T Walsh; Federico A Moretti; Monica Battiston; Mario Mazzucato; Luigi De Marco; Francisco E Baralle; Denisa D Wagner; Andrés F Muro
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-11-08       Impact factor: 8.311

7.  The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.

Authors:  Wolfgang Bergmeier; Crystal L Piffath; Tobias Goerge; Stephen M Cifuni; Zaverio M Ruggeri; Jerry Ware; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Relation between ADAMTS13 activity and ADAMTS13 antigen levels in healthy donors and patients with thrombotic microangiopathies (TMA).

Authors:  Manfred Rieger; Silvia Ferrari; Johanna A Kremer Hovinga; Christian Konetschny; Andrea Herzog; Letizia Koller; Alfred Weber; Giuseppe Remuzzi; Michael Dockal; Barbara Plaimauer; Friedrich Scheiflinger
Journal:  Thromb Haemost       Date:  2006-02       Impact factor: 5.249

9.  Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.

Authors:  Adili Reheman; Hong Yang; Guangheng Zhu; Wuxun Jin; Feng He; Christopher M Spring; Xufang Bai; Peter L Gross; John Freedman; Heyu Ni
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

10.  Systemic antithrombotic effects of ADAMTS13.

Authors:  Anil K Chauhan; David G Motto; Colin B Lamb; Wolfgang Bergmeier; Michael Dockal; Barbara Plaimauer; Friedrich Scheiflinger; David Ginsburg; Denisa D Wagner
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  13 in total

1.  Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4.

Authors:  Prem Prakash; Paresh P Kulkarni; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

2.  Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.

Authors:  Saravanan Subramaniam; Kerstin Jurk; Lukas Hobohm; Sven Jäckel; Mona Saffarzadeh; Kathrin Schwierczek; Philip Wenzel; Florian Langer; Christoph Reinhardt; Wolfram Ruf
Journal:  Blood       Date:  2017-02-21       Impact factor: 22.113

3.  Heme stimulates platelet mitochondrial oxidant production to induce targeted granule secretion.

Authors:  Gowtham K Annarapu; Deirdre Nolfi-Donegan; Michael Reynolds; Yinna Wang; Lauryn Kohut; Brian Zuckerbraun; Sruti Shiva
Journal:  Redox Biol       Date:  2021-12-05       Impact factor: 11.799

Review 4.  Signaling mechanisms of the platelet glycoprotein Ib-IX complex.

Authors:  Yaping Zhang; Samuel M Ehrlich; Cheng Zhu; Xiaoping Du
Journal:  Platelets       Date:  2022-05-26       Impact factor: 4.236

5.  P-selectin can promote thrombus propagation independently of both von Willebrand factor and thrombospondin-1 in mice.

Authors:  P Prakash; M K Nayak; A K Chauhan
Journal:  J Thromb Haemost       Date:  2017-02-03       Impact factor: 5.824

6.  Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.

Authors:  Manasa K Nayak; Nirav Dhanesha; Prakash Doddapattar; Omar Rodriguez; Vijay K Sonkar; Sanjana Dayal; Anil K Chauhan
Journal:  Blood Adv       Date:  2018-08-14

7.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

8.  Zinc finger gene 217 (ZNF217) Promoted Ovarian Hyperstimulation Syndrome (OHSS) through Regulating E2 Synthesis and Inhibiting Thrombospondin-1 (TSP-1).

Authors:  Junyu Zhai; Jiansheng Liu; Xiaoyue Cheng; Shang Li; Yan Hong; Kang Sun; Zi-Jiang Chen; Yanzhi Du; Weiping Li
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

9.  Cooperation of IRAK1/4 inhibitor and ABT-737 in nanoparticles for synergistic therapy of T cell acute lymphoblastic leukemia.

Authors:  Xiaoyan Wu; Lin Wang; Yining Qiu; Bingyu Zhang; Zhenhua Hu; Runming Jin
Journal:  Int J Nanomedicine       Date:  2017-10-31

Review 10.  Inflammation, von Willebrand factor, and ADAMTS13.

Authors:  Junmei Chen; Dominic W Chung
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.